Clinical Trial Update: A Biomarker Study of ATH434 in Participants With MSA [Phase 2]

View source ↗

Summary

A Phase 2 biomarker study evaluating ATH434 in participants with Multiple System Atrophy has completed. The update notes the trial status and completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• ATH434

Snippet

Sponsor: Alterity Therapeutics | Conditions: Multiple System Atrophy | Phase 2 | Status: COMPLETED